Drug intelligence / Profile preview

ISTA Tears (Bausch + Lomb)

Development stage
Unknown
Lead developer
Bausch & Lomb
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

ISTA Tears is a sterile ophthalmic solution originally developed by ISTA Pharmaceuticals (later acquired by Bausch & Lomb) for the symptomatic relief of dry eye disease. It is formulated as a lubricant eye drop, typically containing active ingredients such as glycerin and hypromellose, which serve to supplement the natural tear film. By providing moisture and lubrication to the ocular surface, ISTA Tears helps to alleviate irritation, redness, and discomfort associated with tear film instability and environmental factors. It was evaluated in clinical preference studies against other major lubricant brands like Systane to assess patient comfort and ocular surface protection.

Brand names
ISTA Tears
Other names
Lubricant Eye Drops

Beyond the preview

Go deeper on ISTA Tears (Bausch + Lomb).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ISTA Tears (Bausch + Lomb).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call